Pathological mechanism

Data

Name Phosphatidyl serine (BC-PS) decreases dendritic spine loss

Description

Hypothesis Dendritic Spine Hypothesis Show Other

Extracelular pathological element BC-Phosphatidylserine (BC-PS) Show Other

Intracelular pathological element

Pathological action Reduces Show Other

Process Dendritic Spine Loss Show Other

Process action

Transmitter(s)

Receptor(s)

Channel(s)

Pharmacological Agent

Pharmacological Action

Brain region

Neuron

Cell model

Cellular compartment

PubMed ID 3479526

Citation

AlzWeb

Notes Phosphatidylserine in the treatment of clinically diagnosed alzheimer's disease. The SMID group. (1987). Journal of neural transmission. Supplementum, 24287-292. BC-PS administration to old rats improves the performances in some memory tests. In humans, the effects of BC-PS have been studied by some controlled trials in AD and related cognitive disorders.

Pathology Alzheimer Show Other

Stage Late Show Other

Question Exclude - dietary

Claim